Recurrent implantation failure and inflammatory markers in serum and follicle fluid of women undergoing assisted reproduction
Journal of Reproductive Immunology · 2024-03 · 162 · 104209
DOI: 10.1016/j.jri.2024.104209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024-03. Verfasst von Hannah Nenonen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Lund University, Jan Waldenströms gata 35, 214 28 Malmö, Sweden. Hauptthemen laut MEDLINE: Interleukin-10, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lund University.
Abstract (Originalsprache)
It has been shown previously that the immune system plays a role in implantation and embryo development. The objective was therefore to evaluate cytokine levels and Th1/Th2 ratio in women with recurrent implantation failure in this nested case-control study. Women with no implantation after ≥ 3 embryo transfers were included in the recurrent implantation failure group (n = 29) and were compared with women with successful pregnancy after the first embryo transfer, with an indication of male factor (n = 26). Cytokines analyzed with the Meso scale discovery (MSD) technology Proinflammatory Human Kit 1 and calculated Th1/Th2 ratios were the main outcome measures. In serum there was a difference between the recurrent implantation failure group and the control group in ratios for IFN-γ/IL-10 (p = 0.01), IL-1β/IL-10 (p = 0.04), IL-2/IL-10 (p = 0.00), TNF-α/IL-10 (p = 0.02), IFN-γ/IL-13 (p = 0.01), IL-12/IL-13 (p = 0.02), IL-2/IL-13 (p = 0.00), and TNF-α/IL-13 (p = 0.00), where the control group had higher ratios, i.e. a shift towards a Th1 pro-inflammatory profile before treatment start. In follicular fluid there were differences in ratios between IL-2/IL-10 (p = 0.02), IL-8/IL-10 (p = 0.02), TNF-α/IL-10 (p = 0.02), IFN-γ/IL-13 (p = 0.01), and TNF-α/IL-13 (p = 0.03). The recurrent implantation failure group had higher ratios except for IFN-γ/IL-13, indicating a shift towards a Th1 pro-inflammatory profile in their follicular fluid. Pro-inflammatory activity in both serum and follicle fluid differs in recurrent implantation failure patients and patients with successful assisted reproduction treatment. Women at risk of immune-related recurrent implantation failure could be identified proactively. Because it is taken at a timepoint closer to implantation, ratios in follicular fluid are specifically interesting as risk markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Lund University, Jan Waldenströms gata 35, 214 28 Malmö, Sweden.
- Scanian University Hospital Malmö, Reproductive Medicine Centre, Östra Varvsgatan 11F, 205 02 Malmö, Sweden; Department of Translational Medicine, Lund University, Jan Waldenströms gata 35, 214 28 Malmö, Sweden.
- Department of Translational Medicine, Lund University, Jan Waldenströms gata 35, 214 28 Malmö, Sweden. Electronic address: Ida.Hjelmer@med.lu.se.
Förderung
- Lund University
Zitieren
APA
Nenonen, H., Kondic, A., Henic, E., & Hjelmér, I. (2024). Recurrent implantation failure and inflammatory markers in serum and follicle fluid of women undergoing assisted reproduction. Journal of Reproductive Immunology, 162, 104209. https://doi.org/10.1016/j.jri.2024.104209
Vancouver
Nenonen H, Kondic A, Henic E, Hjelmér I. Recurrent implantation failure and inflammatory markers in serum and follicle fluid of women undergoing assisted reproduction. Journal of Reproductive Immunology. 2024;162:104209. doi:10.1016/j.jri.2024.104209
BibTeX
@article{Nenonen2024,
author = {Nenonen, Hannah and Kondic, Alexandra and Henic, Emir and Hjelmér, Ida},
title = {Recurrent implantation failure and inflammatory markers in serum and follicle fluid of women undergoing assisted reproduction},
journal = {Journal of Reproductive Immunology},
year = {2024},
volume = {162},
pages = {104209},
doi = {10.1016/j.jri.2024.104209}
}
EUVIMED